about
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesIdentification of semaphorin E as a non-MDR drug resistance gene of human cancersFine tuning chemotherapy to match BRCA1 statusScreen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.Vitamin e is a nephroprotectant agent in male but not in female in a model of Cisplatin-induced nephrotoxicityCisplatin-based therapy: a neurological and neuropsychological review.The frequencies of micronuclei induced by cisplatin in newborn rat astrocytes are increased by 50-Hz, 7.5- and 10-mT electromagnetic fieldsCellular responses to Cisplatin-induced DNA damage.Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathyGlutathione and drug resistance.Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.Ameliorative influence of Urtica dioica L against cisplatin-induced toxicity in mice bearing Ehrlich ascites carcinoma.5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferretAPE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NEREffect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin against Drug-Resistant Ovarian Cancer CellsRelationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.Therapeutic interventions to disrupt the protein synthetic machinery in melanomaRole of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell linesCombined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.Effect of cisplatin administration on the proliferation and differentiation of bone marrow cells of tumour-bearing mice.Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNASalidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signallingA Comprehensive Review on the Genetic Regulation of Cisplatin-induced NephrotoxicityThe antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrewPost-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.Comparison of different sample preparation methods for platinum determination in cultured cells by graphite furnace atomic absorption spectrometry.Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.Vitamin C protects against cisplatin-induced nephrotoxicity and damage without reducing its effectiveness in C57BL/6 mice xenografted with Lewis lung carcinoma.Comparison of the cytotoxic effects of Juniperus sabina and Zataria multiflora extracts with Taxus baccata extract and Cisplatin on normal and cancer cell lines.Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.Copper(II) and manganese(III) complexes of N'-[(2-hydroxy phenyl) carbonothioyl] pyridine-2-carbohydrazide: novel therapeutic agents for cancer.Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.LFA-1-dependent tumoricidal activity of cisplatin-treated macrophages.
P2860
Q24289008-1AB25CFE-DB12-48B5-AB7E-A934747AFBA5Q24315145-BF0B74DF-BBD8-4048-BE95-F3197ABCE637Q27694529-F97E958E-BEC7-408F-B6A5-0FE46B48668EQ30446543-10105B04-E615-40F4-AFF8-8383966D524FQ30898130-065C037D-CECD-407A-AC36-C969B7D4D5FFQ33385228-12138787-E9C6-4DF0-927D-71A6925F3D53Q33710810-DF8C9FA9-E95F-417F-8680-3E775FEED7B0Q33833882-385435C1-D317-49E4-B6C8-5793974605ABQ33854150-F409EBCB-90DF-4B0C-BE80-735A18553BB2Q34089685-61479A33-3C7F-4CE6-AC8A-18660A0D4F9BQ34133825-0CF5EBA5-6804-4D48-9662-A209A2ADE0CBQ34374824-2E38CA4B-F284-4998-A963-78B954423994Q34585575-D87A152D-AD22-4A7D-BC15-114CE4F84A38Q34632527-5491253A-72A1-4DA3-BDA4-034FD6DF0197Q35756396-56DF4B0D-E194-4C8A-8F9B-EC9B30843454Q36011912-8B838E03-CB10-4243-A8A8-DFF5E2B65748Q36135764-66835AAD-F951-4582-B897-821CE09CE550Q36291991-68042245-45C1-44F3-A3CA-B2926C464DDAQ36377590-946B695C-9A62-45EE-8219-495CA8313FCFQ36422416-B44CB383-6947-447F-AF56-F7CA38A7C149Q36473355-DCBC4A73-1D24-408C-AF87-859801F7EE4CQ36648770-6F63542F-1CDF-408B-B371-DB316AAFE378Q36663659-EE69B39B-0030-474D-88DF-82EFC2CA2B7BQ36685163-825775F1-5FBB-471B-97DB-8B5EA2D23224Q36688531-82225692-9F85-4295-A653-D9C9C61E68C2Q36892992-4BAE2EC0-8389-4496-917D-FE1FAC131810Q36906569-8E33B317-610E-4ED1-BEE5-3422ABD2B778Q37101114-1596FB88-6021-41E1-BA14-8B25020B1662Q37139289-EB8976D1-E732-42FE-987F-F1A500A02523Q37346039-7CA9ACFA-88C8-4547-9AAC-3C4FC4F8D70DQ37408713-43C69123-2B3B-4600-9890-7A488391781BQ37484424-718D996A-E25E-4571-BAEF-FF06720FF5C2Q37595883-F9E57795-C62C-44FC-82A3-9BB0C11BB996Q37989844-8BF62B3C-BD81-4512-90AD-4181901DF590Q38962740-A50EA9C0-A1B4-4DF7-95A7-54C07D8F48FEQ39674090-A86CBEC5-3F32-41D7-991C-DC85A1E0BD01Q39981513-51B7D585-AFB2-469B-9FC7-8D6158C4CF84Q40294929-1874D4BB-B579-4740-A247-7AEF868A82D1Q40718608-1BE12FDB-6C33-4CFB-8D37-6D34F9791566Q41011853-2CFBB774-FD91-462B-830C-EE1B75F78935
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Fundamental studies with cisplatin.
@en
Fundamental studies with cisplatin.
@nl
type
label
Fundamental studies with cisplatin.
@en
Fundamental studies with cisplatin.
@nl
prefLabel
Fundamental studies with cisplatin.
@en
Fundamental studies with cisplatin.
@nl
P1433
P1476
Fundamental studies with cisplatin.
@en
P2093
Rosenberg B
P2860
P304
P356
10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L
P407
P577
1985-05-01T00:00:00Z